Mental health: current trends in pharmacy and new concepts
DOI:
https://doi.org/10.14739/2409-2932.2023.3.285412Keywords:
mental health, pharmaceutical care, psychosocial support, Good Pharmacy Practice, pharmaceutical provisionAbstract
The implementation of the National Mental Health Gap Action Program (mhGAP), which aims to broaden the management of patients with mental disorders in primary care, should involve not only primary care physicians but also pharmacists. Pharmacists play a crucial role by providing medications within the expanded Medical Guarantee Program for drug reimbursement in outpatient treatment of mental and behavioral disorders. Additionally, they offer pharmaceutical care for patients dealing with stress disorders and insomnia, adhering to the Good Pharmacy Practice (GPP) standards.
The aim of the work is the study of national information, scientific databases, and scientometric databases of Scopus, Web of Science, PubMed, Cochrane Library in order to identify, generalize, and systematize the source based on providing pharmaceutical care in the field of mental health care of patients and predicting the future vector of research on the specified topic.
Materials and methods. General scientific methods such as analysis, synthesis, comparison, and data generalization from domestic information and scientific databases were employed in this study. To search for scientific publications, the VOS viewer visualization program, the PubMed search engine, and the Cochrane Library were used. The keywords “mental health” and “pharmacy” were used for the search within the scientometric databases of Scopus and Web of Science.
Results. The analysis of the main strategies for the development of pharmaceutical care for mental health care in pharmaceutical practice was carried out. The most researched clusters of mental health care were singled out. Modern trends in the development of pharmaceutical care for mental health care were summarized.
Conclusions. The initiative for enhancing mental health care for the country’s population hinges on the principles of a novel, sustainable, patient-centered pharmacy model. This approach necessitates the realization of an expanded role for pharmacists, aligning with the standards outlined in Good Pharmacy Practice.
References
World Health Organization. (2022). Priorytetni bahatosektorni zakhody z psykhichnoho zdorovia ta psykhosotsialnoi pidtrymky v Ukraini pid chas ta pislia viiny: operatyvna dorozhnia karta [Priority multisectoral interventions for mental health and psychosocial support in Ukraine during and after the war: an operational road map]. https://www.humanitarianresponse.info/sites/www.humanitarianresponse.info/files/documents/files/mhpss_framework_ukraine_ukr.pdf
World Health Organization. (2020). Kerivnytstvo mhGAP: dlia vedennia psykhichnykh, nevrolohichnykh rozladiv i rozladiv, poviazanykh zi vzhyvanniam psykhoaktyvnykh rechovyn, u nespetsializovanykh zakladakh okhorony zdorovia, versiia 2 [mhGAP guideline: for the management of psychiatric, neurological and substance use disorders in non-specialist health care settings, version 2.0]. License: CC BY-NC-SA 3.0 IGO. https://apps.who.int/iris/handle/10665/334239
Cabinet of Ministers of Ukraine. (2022, December 27). Deiaki pytannia realizatsii prohramy derzhavnykh harantii medychnoho obsluhovuvannia naselennia u 2023 rotsi [Some issues of implementation of the program of state guarantees of medical care of the population in 2023 (No. 1464)]. https://zakon.rada.gov.ua/laws/show/1464-2022-п#Text
Ministry of Health of Ukraine. (2022, January 5). Pro zatverdzhennia protokoliv farmatsevta [On approval of pharmacist protocols (No. 7)]. https://zakon.rada.gov.ua/rada/show/v0007282-22#Text
Ministry of Health of Ukraine. (2011, January 1). Nalezhna aptechna praktyka: Standarty yakosti aptechnykh posluh (Spilna nastanova MFF/VOOZ z NAP) [Proper Pharmacy Practice: Quality Standards of Pharmacy Services]. https://zakon.rada.gov.ua/rada/show/897_009#n2
World Health Organization. (2022, 17 June). Mental health. https://www.who.int/news-room/fact-sheets/detail/mental-health-strengthening-our-response
World Health Organization. (2022, June 16). World mental health report: transforming mental health for all. World Health Organization. License: CC BY-NC-SA 3.0 IGO. https://apps.who.int/iris/handle/10665/356119
Swati Rana (2022, 7 July). FIP encourages pharmacists to expand roles in «much needed» mental health services. Pharmacy Business. https://www.pharmacy.biz/news/fip-encourages-pharmacists-to-expand-roles-in-much-needed-mental-health-services/
The Pharmacy Guild of Australia. (2010). Community Pharmacy Roadmap Program Development Template. Retrieved Jul 18, 2023, from https://www.guild.org.au/__data/assets/pdf_file/0021/5493/mental-illness-services.pdf
Royal Pharmaceutical Society. (2022, October 16). The Role of Pharmacy in Mental Health wellbeing. Retrieved Jul 18, 2023, from https://www.rpharms.com/recognition/all-our-campaigns/policy-a-z/the-role-of-pharmacy-in-mental-health-and-wellbeing
National Community Pharmacists Association. (n.d.). Mental Health First Aid. https://ncpa.org/mental-health-first-aid
European Commission. (2023). Mental Health. A comprehensive approach to Mental Health. https://health.ec.europa.eu/non-communicable-diseases/mental-health_en
Council of Europe. (2020, March 11). Resolution CM/Res (2020)3 on the implementation of pharmaceutical care for the benefit of patients and Health services. https://rm.coe.int/09000016809cdf26
Cabinet of Ministers of Ukraine. (2017, December 27). Pro skhvalennia Kontseptsii rozvytku okhorony psykhichnoho zdorovia v Ukraini na period do 2030 roku (No. 1018-r) [On the approval of the Concept of Mental Health Care Development in Ukraine for the period until 2030 (No. 1018-r)]. https://zakon.rada.gov.ua/laws/show/1018-2017-р#Text
MH4U. (n.d.). Mental Health for Ukraine. https://www.mh4u.in.ua/about/
Aburas, W., & Alshammari, T. M. (2020). Pharmacists' roles in emergency and disasters: COVID-19 as an example. Saudi pharmaceutical journal : SPJ, 28(12), 1797-1816. https://doi.org/10.1016/j.jsps.2020.11.006
Jacobs, S., Johnson, S., & Hassell, K. (2018). Managing workplace stress in community pharmacy organisations: lessons from a review of the wider stress management and prevention literature. The International journal of pharmacy practice, 26(1), 28-38. https://doi.org/10.1111/ijpp.12360
Bjerkeli, P. J., Skoglund, I., & Holmgren, K. (2020). Does early identification of high work related stress affect pharmacological treatment of primary care patients? - analysis of Swedish pharmacy dispensing data in a randomised control study. BMC family practice, 21(1), 70. https://doi.org/10.1186/s12875-020-01140-x
McMillan, S. S., Kelly, F., Hattingh, H. L., Fowler, J. L., Mihala, G., & Wheeler, A. J. (2018). The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes. Journal of mental health, 27(2), 164-173. https://doi.org/10.1080/09638237.2017.1340618
Kamusheva, M., Ignatova, D., Golda, A., & Skowron, A. (2020). The Potential Role of the Pharmacist in Supporting Patients with Depression - A Literature-Based Point of View. Integrated pharmacy research & practice, 9, 49-63. https://doi.org/10.2147/IPRP.S239672
Akour, A., Halloush, S., Nusair, M. B., Barakat, M., Abdulla, F., & Al Momani, M. (2022). Gaps in pharmaceutical care for patients with mental health issues: A cross-sectional study. International journal of clinical pharmacy, 44(4), 904-913. https://doi.org/10.1007/s11096-022-01391-x
UkrINTEI (2023). Natsionalnyi repozytarii akademichnykh tekstiv [National repository of academic texts]. Retrieved Jul 18, 2023, from https://nrat.ukrintei.ua/searchdb/?_token=JsmsLfg1niuTYfbBd59MWi3bwtQokY11Mdhe2LnK&typeSearch2=okd&authorSearch=&specialnistSearch=15.00.01&temaSearch2=&textSearch=&dateFromSearch=2013-01-01&dateToSearch=2023-07-16®istrationNumberSearch=&sortOrder=registration_date&sortDir=desc&tab=big
Nemchenko, A. S., Liadenko, A. V., Nemchenko, O. A., & Lebed, S. O. (2023). Assessment of the availability of medicines for patients with mental and behavioral disorders based on the results of a survey of doctors and pharmacists in Ukraine. ScienceRise: Pharmaceutical Science, (3), 16-22. [in Ukrainian]. https://doi.org/10.15587/2519-4852.2023.281222
Tkachova, O., Iakovlieva, L., Gerasymova, O., Butko, Y., & Kovalenko, L. (2023). Comparative analysis of the consumption of antidepressants in Ukraine, Estonia and Norway. ScienceRise: Pharmaceutical Science, (3), 23-30. https://doi.org/10.15587/2519-4852.2023.281833
John Wiley & Sons, Inc. (2023). Cochrane Library. Retrieved Jul 18, 2023, from https://www.cochranelibrary.com/search
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)